These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15342309)

  • 21. Effects of cardiac resynchronization therapy on ventricular repolarization in patients with congestive heart failure.
    Berger T; Hanser F; Hintringer F; Poelzl G; Fischer G; Modre R; Tilg B; Pachinger O; Roithinger FX
    J Cardiovasc Electrophysiol; 2005 Jun; 16(6):611-7. PubMed ID: 15946359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged paced QRS duration as a predictor for congestive heart failure in patients with right ventricular apical pacing.
    Miyoshi F; Kobayashi Y; Itou H; Onuki T; Matsuyama T; Watanabe N; Liu C; Kawamura M; Asano T; Miyata A; Nakagawa H; Tanno K; Baba T; Katagiri T
    Pacing Clin Electrophysiol; 2005 Nov; 28(11):1182-8. PubMed ID: 16359284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac resynchronization therapy: retiming the failing right ventricle.
    Cowburn PJ; Parker JD; Cameron DA; Harris L
    J Cardiovasc Electrophysiol; 2005 Apr; 16(4):439-43. PubMed ID: 15828891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts.
    McAlister FA; Tu JV; Newman A; Lee DS; Kimber S; Cujec B; Armstrong PW
    Eur Heart J; 2006 Feb; 27(3):323-9. PubMed ID: 16105850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimized cardiac resynchronization therapy in patients with congestive heart failure.
    Niu HX; Hua W; Zhang S; Sun X; Chen KP; Wang FZ; Chen X
    Chin Med J (Engl); 2007 Apr; 120(7):605-7. PubMed ID: 17442212
    [No Abstract]   [Full Text] [Related]  

  • 26. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrioventricular node ablation is not a prerequisite for cardiac resynchronization therapy in patients with chronic atrial fibrillation.
    Schütte F; Lüdorff G; Grove R; Kranig W; Thale J
    Cardiol J; 2009; 16(3):246-9. PubMed ID: 19437399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triple-site biventricular pacing in patients undergoing cardiac resynchronization therapy: a feasibility study.
    Lenarczyk R; Kowalski O; Kukulski T; Szulik M; Pruszkowska-Skrzep P; Zielinska T; Kowalczyk J; Pluta S; Duszanska A; Sredniawa B; Musialik-Lydka A; Kalarus Z
    Europace; 2007 Sep; 9(9):762-7. PubMed ID: 17631515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
    Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
    Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual-site left ventricular cardiac resynchronization therapy.
    Padeletti L; Colella A; Michelucci A; Pieragnoli P; Ricciardi G; Porciani MC; Tronconi F; Hettrick DA; Valsecchi S
    Am J Cardiol; 2008 Dec; 102(12):1687-92. PubMed ID: 19064025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined longitudinal and radial dyssynchrony predicts ventricular response after resynchronization therapy.
    Gorcsan J; Tanabe M; Bleeker GB; Suffoletto MS; Thomas NC; Saba S; Tops LF; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2007 Oct; 50(15):1476-83. PubMed ID: 17919568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac uptake of progenitor cells in patients with moderate-to-severe left ventricular failure scheduled for cardiac resynchronization therapy.
    Goette A; Jentsch-Ullrich K; Hammwöhner M; Trautmann S; Franke A; Klein HU; Auricchio A
    Europace; 2006 Mar; 8(3):157-60. PubMed ID: 16627431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mid-term outcomes of triple-site vs. conventional cardiac resynchronization therapy: a preliminary study.
    Lenarczyk R; Kowalski O; Kukulski T; Pruszkowska-Skrzep P; Sokal A; Szulik M; Zielińska T; Kowalczyk J; Pluta S; Sredniawa B; Musialik-Łydka A; Kalarus Z
    Int J Cardiol; 2009 Mar; 133(1):87-94. PubMed ID: 18242737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time intervals of cardiac resynchronization therapy in heart failure.
    Baker C; Love CJ; Moeschberger ML; Orsinelli DA; Yamokoski L; Leier CV
    Am J Cardiol; 2004 Nov; 94(9):1192-6. PubMed ID: 15518621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac resynchronization therapy: long-term alternative to cardiac transplantation?
    Hansky B; Vogt J; Zittermann A; Güldner H; Heintze J; Schulz U; Horstkotte D; Tenderich G; Körfer R
    Ann Thorac Surg; 2009 Feb; 87(2):432-8. PubMed ID: 19161754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of temporary biventricular pacing in the cardiac surgical patient with severely reduced left ventricular systolic function.
    Evonich RF; Stephens JC; Merhi W; Dukkipati S; Tepe N; Shannon F; Altshuler J; Sakwa M; Bassett J; Hanson E; Boura J; O'Neill WW; Haines DE
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):915-21. PubMed ID: 18954630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. QRS duration alone misses cardiac dyssynchrony in a substantial proportion of patients with chronic heart failure.
    Perry R; De Pasquale CG; Chew DP; Aylward PE; Joseph MX
    J Am Soc Echocardiogr; 2006 Oct; 19(10):1257-63. PubMed ID: 17000365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
    Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
    J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardiac resynchronization therapy in refractory heart failure].
    Lelakowski J; Czunko A; Majewski J; Bednarek J; Małecka B; Dreher A; Kołacz P
    Pol Merkur Lekarski; 2005 Apr; 18(106):440-5. PubMed ID: 16161931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.